FDA Approves COVID Vaccines Targeting KP.2 Variant
FDA Approves COVID Vaccines Targeting KP.2 Variant
FDA Approves COVID Vaccines Targeting KP.2 Variant
News summary

The latest COVID-19 vaccines, updated to target the KP.2 variant, are now available following FDA approval, with CDC recommending vaccination for everyone aged 6 months and older. As respiratory virus season nears, the CDC also advises flu shots, which can be administered alongside COVID-19 vaccines. However, uninsured Americans face high costs for COVID-19 vaccines due to the expiration of federal funding, with doses priced up to $200. Pharmacies like Walgreens, CVS, and Weis Markets are rolling out the new vaccines, while Pfizer and Moderna may offer patient assistance programs with unclear eligibility. Research highlights that factors such as stress, exercise, and hormonal birth control may influence vaccine side effects, emphasizing the need for personalized health approaches.

Story Coverage
Bias Distribution
63% Left
Information Sources
bfb2a97b-336e-48d9-b69a-147df7862dc2cad3d7a8-9ce2-4060-a6fb-3964c8b50089a8525413-d1cb-4a36-b99e-5987ae74bd31d387b58c-602b-49e7-8f0e-990aad2baa47
+2
Left 63%
R
Coverage Details
Total News Sources
8
Left
5
Center
0
Right
1
Unrated
2
Last Updated
12 days ago
Bias Distribution
63% Left
Related News
Daily Index

Negative

20Serious

Neutral

Optimistic

Positive

Ask VT AI
Story Coverage

Related Topics

Subscribe

Stay in the know

Get the latest news, exclusive insights, and curated content delivered straight to your inbox.

Related News
Recommended News